Terminal Access

Unlimited access to the most powerful analytical tools in finance.

Bloomberg Fair Value
20M Securities
50Y History
10Y Estimates
8.000+ News Daily
Subscribe for $2
Overview
Profile

PPD stock

PPD
US69355F1021
A2PX5V

Price

47.28
Today +/-
+0
Today %
+0 %

PPD stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the PPD stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the PPD stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the PPD stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze PPD's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

PPD Stock Price History

DatePPD Price
12/9/202147.28 undefined
12/8/202147.28 undefined

PPD Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into PPD, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by PPD from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects PPD’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of PPD. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into PPD’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing PPD’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on PPD’s growth potential.

PPD Revenue, EBIT and net profit per share

DatePPD RevenuePPD EBITPPD Net Income
2025e8.03 B undefined0 undefined946.02 M undefined
2024e7.47 B undefined0 undefined830.35 M undefined
2023e7.02 B undefined0 undefined736.11 M undefined
2022e6.43 B undefined0 undefined644.42 M undefined
2021e6.07 B undefined0 undefined567.11 M undefined
20204.68 B undefined509.4 M undefined153.7 M undefined
20194.03 B undefined418.5 M undefined47.8 M undefined
20183.75 B undefined402.2 M undefined104.2 M undefined
20173 B undefined376.1 M undefined296 M undefined
20162.68 B undefined314.3 M undefined183.1 M undefined

PPD Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
201620172018201920202021e2022e2023e2024e2025e
2.6833.754.034.686.076.437.027.478.03
-12.0224.937.5216.1329.765.939.116.457.51
48.2348.7839.3240.2438.4129.6027.9525.6124.0622.38
1.291.461.471.621.800000
18329610447153567644736830946
-61.75-64.86-54.81225.53270.5913.5814.2912.7713.98
339.4339.4327328.6346.700000
----------
Details

Keystats

ⓘ

Revenue and Growth

The PPD Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the PPD is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (B)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (B)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
2017201820192020
       
419553.1345.2768
1.121.261.331.61
3216.127.522.4
0000
94.2102.3119.8146.1
1.671.931.822.55
384.2399.1640.4668.3
276274.5284.4309.1
0000
1.221.030.890.75
1.791.721.761.82
109131.3156.2201.6
3.783.563.743.75
5.445.495.566.29
       
2.82.82.83.5
0.020.0401.82
-1,282.1-1,245.1-2,391.3-2,271.8
-234.4-312.9-298.9-284.8
0000
-1,491.7-1,513.5-2,685.4-733.2
96.789130.1176.3
390.9384.7493578.6
1.111.291.451.49
0000
35.134.935.836.2
1.641.792.112.28
4.794.765.614.23
217.5165.192.254.5
274.7266.3416.9447.1
5.285.196.124.73
6.916.998.227.01
5.425.475.546.27
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of PPD provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand PPD's financial health and stability.

Assets

PPD's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that PPD must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of PPD after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into PPD's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (B)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
20162017201820192020
18230010652160
260279259264279
-43-317-26-84-38
29594991-287
-213633109138
000300260
131007271
408359423432251
-90-105-116-125-163
-519-92-90-233-145
-4291225-10717
00000
626515-35853-1,466
00-0.0101.8
130-249-166-422280
-496.00-763.00-123.00-1,276.00-49.00
00000
-457134-207422
00000
00000

PPD stock margins

The PPD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PPD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PPD.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the PPD's sales revenue. A higher gross margin percentage indicates that the PPD retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the PPD's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the PPD's total revenue generated. When comparing the revenue margin year over year, investors can gauge the PPD's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the PPD. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the PPD's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

PPD Margin History

PPD Gross marginPPD Profit marginPPD EBIT marginPPD Profit margin
2025e38.42 %0 %11.77 %
2024e38.42 %0 %11.11 %
2023e38.42 %0 %10.49 %
2022e38.42 %0 %10.02 %
2021e38.42 %0 %9.34 %
202038.42 %10.88 %3.28 %
201940.24 %10.38 %1.19 %
201839.32 %10.73 %2.78 %
201748.8 %12.53 %9.86 %
201648.25 %11.73 %6.83 %

PPD Stock Sales Revenue, EBIT, Earnings per Share

The PPD earnings per share therefore indicates how much revenue PPD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue PPD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates PPD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of PPD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating PPD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

PPD Revenue, EBIT and net profit per share

DatePPD Sales per SharePPD EBIT per sharePPD Earnings per Share
2025e22.95 undefined0 undefined2.7 undefined
2024e21.34 undefined0 undefined2.37 undefined
2023e20.05 undefined0 undefined2.1 undefined
2022e18.38 undefined0 undefined1.84 undefined
2021e17.35 undefined0 undefined1.62 undefined
202013.5 undefined1.47 undefined0.44 undefined
201912.27 undefined1.27 undefined0.15 undefined
201811.46 undefined1.23 undefined0.32 undefined
20178.84 undefined1.11 undefined0.87 undefined
20167.9 undefined0.93 undefined0.54 undefined

PPD business model

PPD Inc is a global company for medical research and services that was founded in 1985 and is headquartered in Wilmington, North Carolina, USA. The company is known for its ability to conduct clinical trials and develop research programs for the biopharmaceutical and medical industry. PPD is a leading provider of comprehensive, integrated services for phases I-IV of clinical research, from non-interventional studies to contract research for pharmaceutical and biotech clients. PPD's business model is based on three key pillars to provide customers with a broad portfolio of services: the first pillar is comprehensive clinical research required for drug registration with regulatory authorities, the second pillar focuses on providing research-based data and analytical methods to facilitate decision-making and risk assessment in the healthcare sector, and the third pillar encompasses extensive laboratory analyses and diagnostic tests to improve patient health and support research efforts. PPD has multiple divisions focused on specific markets and customers. The Clinical Trials division offers services for drug development up to approval by regulatory authorities, including the setup and monitoring of clinical trials and statistical analysis of test results. The Data Management division provides data capture and management solutions for clinical trials to ensure high data quality and compliance with regulations. The Medical Monitoring division offers medical consultation and monitoring during clinical trials. PPD also has a division for Real World Evidence studies, which collects data from routine clinical practice to assess the safety and efficacy of drugs. PPD has made some important acquisitions in the past to strengthen its presence in the industry. In 2011, PPD was acquired by private equity firms Carlyle Group and Hellman & Friedman, becoming a private company. In 2020, PPD went public. In 2018, PPD acquired Evidera, a company specializing in clinical epidemiology and outcomes research. In 2019, PPD acquired Q-Squared Solutions, expanding its extensive laboratory analysis and diagnostic testing capabilities. PPD's offerings include a wide range of products and services, including unique planning and implementation solutions that enable efficient conduct of clinical trials. These solutions also include electronic data capture and management systems, as well as statistical analysis tools. PPD also offers specialized services, such as training programs for clinical investigators and staff. PPD aims to enable safe, faster, and cost-effective drug development through clinical research. In the future, PPD will continue to expand its business model and services to meet the needs of its customers in the changing industry and support innovative research programs. PPD is one of the most popular companies on Eulerpool.com.

PPD SWOT Analysis

Strengths

PPD Inc. possesses several key strengths that contribute to its success and competitive advantage:

  • Strong reputation and brand recognition in the industry.
  • Diverse portfolio of products and services, catering to various market segments.
  • Well-established distribution network, ensuring wide market coverage.
  • Highly skilled and experienced workforce, fostering innovation and efficiency.

Weaknesses

Despite its strengths, PPD Inc. also faces certain weaknesses that pose challenges:

  • Reliance on a limited number of key customers, increasing vulnerability to changes in their preferences or market conditions.
  • Higher operational costs compared to some competitors.
  • Limited geographic reach, potentially missing out on untapped markets.
  • Integration and communication challenges across different departments and divisions within the organization.

Opportunities

PPD Inc. has identified several opportunities that it can capitalize on:

  • Expanding into emerging markets with high growth potential.
  • Developing new and innovative products to meet evolving customer needs.
  • Acquiring smaller competitors to strengthen market position and increase market share.
  • Forming strategic partnerships or collaborations to access new technologies or markets.

Threats

PPD Inc. also faces certain threats that may impact its growth and profitability:

  • Intense competition from existing and new players in the market.
  • Changing regulatory landscapes and compliance requirements.
  • Economic downturns or fluctuations, affecting customer spending and demand.
  • Rapid technological advancements, necessitating continuous adaptation and investment.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

PPD Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

PPD historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

PPD shares outstanding

The number of shares was PPD in 2024 — This indicates how many shares 346.7 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue PPD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates PPD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of PPD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating PPD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for PPD.

PPD shareholders

%
Name
Stocks
Change
Date
22.02569 % H&F Globe Investor LP77,118,53509/30/2021
15.91487 % The Carlyle Group55,722,73309/30/2021
15.91487 % H&F Corporate Investors VIII Ltd55,722,73109/30/2021
6.15814 % GIC Private Limited21,561,496-4,023,67712/31/2020
6.13262 % Abu Dhabi Investment Authority21,472,151-4,113,02212/31/2020
3.42223 % The Vanguard Group, Inc.11,982,2651,314,0489/30/2021
3.03887 % Pentwater Capital Management LP10,640,000-1,580,0009/30/2021
1.66822 % Goldman Sachs & Company, Inc.5,840,9421,011,7669/30/2021
1.55693 % BlackRock Institutional Trust Company, N.A.5,451,279156,2209/30/2021
1.44138 % Fidelity International5,046,7001,041,2009/30/2021
1
2
3
4
5
...
10

Most common questions regarding PPD

What values and corporate philosophy does PPD represent?

PPD Inc represents a strong set of values and a clear corporate philosophy. The company focuses on delivering exceptional customer service, fostering a culture of innovation, and maintaining the highest standards of integrity. PPD Inc aims to provide reliable and efficient solutions in the fields of healthcare and clinical research. With its commitment to excellence, PPD Inc strives to deliver value to its clients and contribute to better patient outcomes. The company's dedication to these principles has established it as a trusted leader in the industry, making PPD Inc a go-to choice for businesses and individuals seeking reliable healthcare and clinical research services.

In which countries and regions is PPD primarily present?

PPD Inc primarily operates in over 50 countries and regions worldwide. With a strong global presence, the company offers its comprehensive range of clinical research and laboratory services to clients across various industries. PPD Inc's key markets include the United States, Europe, Asia Pacific, and Latin America. The company's extensive network and expertise allow it to effectively serve clients on a global scale, helping them navigate the complexities of drug development and deliver innovative solutions. PPD Inc's commitment to expanding its presence in emerging markets reinforces its position as a leading provider of life sciences services worldwide.

What significant milestones has the company PPD achieved?

PPD Inc has achieved significant milestones throughout its history. Some noteworthy achievements include successfully conducting over 230,000 clinical trials, establishing a global presence in more than 46 countries, and consistently delivering innovative solutions to the life sciences industry. The company has also been recognized for its exceptional expertise in clinical research, data management, and regulatory affairs. PPD Inc's commitment to quality and customer satisfaction has enabled it to be a reliable partner for pharmaceutical, biotechnology, and medical device companies worldwide. With its strong track record and industry leadership, PPD Inc continues to make significant strides in advancing healthcare and improving patient outcomes.

What is the history and background of the company PPD?

PPD Inc is a leading global contract research organization (CRO) specializing in drug development, laboratory services, and clinical trial management. Founded in 1985, PPD has a rich history and a strong background in providing innovative solutions to the pharmaceutical, biotechnology, and medical device industries. The company offers a comprehensive range of services, including early development, clinical research, laboratory services, and post-approval studies. PPD Inc has established itself as a trusted partner for the life sciences industry, delivering high-quality results, efficiency, and expertise in advancing healthcare solutions. With a global presence and a team of experienced professionals, PPD continues to be at the forefront of advancing clinical research and improving patient outcomes.

Who are the main competitors of PPD in the market?

The main competitors of PPD Inc in the market include QuintilesIMS, LabCorp, Icon, and Covance.

In which industries is PPD primarily active?

PPD Inc is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of PPD?

PPD Inc is a leading global contract research organization (CRO) providing comprehensive, integrated drug development and laboratory services. Their business model revolves around offering end-to-end solutions to pharmaceutical and biotech companies, guiding them through the entire drug development process. PPD Inc offers a wide range of services including clinical research, data management, biostatistics, and regulatory affairs. With a focus on quality, efficiency, and innovation, PPD Inc helps clients accelerate the development of life-changing therapies. Through their extensive expertise, efficient processes, and strategic partnerships, PPD Inc plays a crucial role in advancing healthcare outcomes and bringing new treatments to patients worldwide.

What is the P/E ratio of PPD 2025?

The PPD P/E ratio is 17.33.

What is the P/S ratio of PPD 2025?

The PPD P/S ratio is 2.04.

What is the Quality Investing of PPD?

The Quality Investing for PPD is 3/10.

What is the revenue of PPD 2025?

The expected PPD revenue is 8.03 B USD.

How high is the profit of PPD 2025?

The expected PPD profit is 946.02 M USD.

What is the business model of PPD

PPD Inc is an international pharmaceutical company headquartered in the USA with branches in Europe, Asia, Africa, and Australia. The company operates in the areas of clinical research, pharmacovigilance, laboratory services, and consulting, offering comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. One of PPD's main divisions is clinical research. The company works closely with pharmaceutical and biotechnology companies, as well as academic research institutions, to conduct clinical trials. PPD provides all the necessary services for conducting a clinical trial, from study design to subject recruitment, data analysis, and reporting. PPD has extensive experience in all phases of clinical research, from Phase I to Phase IV, and has successfully brought numerous drugs to market in the past. Another important division of PPD is pharmacovigilance. Here, the company collects and analyzes data on adverse drug reactions and provides recommendations for risk minimization. PPD works closely with regulatory authorities worldwide to ensure that all data on adverse drug reactions are accurately recorded and analyzed. In addition, PPD offers laboratory services. The company's portfolio includes a wide range of laboratory tests, including bioanalytical tests and safety tests. PPD has extensive expertise in analyzing biological samples, including blood, urine, saliva, and stool samples. The company specializes in identifying molecular markers that are important for disease diagnosis or monitoring therapy success. PPD also offers comprehensive consulting services. Here, the company supports its clients in the development of new therapies and drugs and provides recommendations for optimizing study design and methods. PPD has extensive experience in working with the FDA and other regulatory authorities worldwide, developing strategies for risk minimization and compliance with regulatory requirements. PPD offers a wide range of products and services specifically tailored to the needs of pharmaceutical and biotechnology companies. The company is committed to offering innovative solutions to its clients to accelerate the development of new drugs and therapies. To this end, PPD has made significant investments in its research and development activities in recent years and works closely with customers and partners to develop new and innovative treatment options. Overall, PPD's business model is oriented towards the needs of the pharmaceutical and biotechnology industry. The company offers comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. PPD is a key partner for innovation in drug development and has successfully brought numerous therapies and drugs to market in the past.

What is the PPD dividend?

PPD pays a dividend of 0 USD distributed over payouts per year.

How often does PPD pay dividends?

The dividend cannot currently be calculated for PPD or the company does not pay out a dividend.

What is the PPD ISIN?

The ISIN of PPD is US69355F1021.

What is the PPD WKN?

The WKN of PPD is A2PX5V.

What is the PPD ticker?

The ticker of PPD is PPD.

How much dividend does PPD pay?

Over the past 12 months, PPD paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PPD is expected to pay a dividend of 0 USD.

What is the dividend yield of PPD?

The current dividend yield of PPD is .

When does PPD pay dividends?

PPD pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PPD?

PPD paid dividends every year for the past 0 years.

What is the dividend of PPD?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PPD located?

PPD is assigned to the 'Health' sector.

Wann musste ich die Aktien von PPD kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PPD from 4/14/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/14/2025.

When did PPD pay the last dividend?

The last dividend was paid out on 4/14/2025.

What was the dividend of PPD in the year 2024?

In the year 2024, PPD distributed 0 USD as dividends.

In which currency does PPD pay out the dividend?

The dividends of PPD are distributed in USD.

All fundamentals about PPD

Our stock analysis for PPD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PPD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.